Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-Risk Cardiomyopathy Genotypes and Arrhythmic Risk: LMNA, FLNC, RBM20, PLN and Desmosomal Genes in the ESC 2023 Era.

Genes - 25 Mar 2026

Tetaj Nardi, Segreti Andrea, Ferro Aurora, Ligorio Virginia, Spagnolo Alberto, Grigioni Francesco

Abstract excerpt

Inherited cardiomyopathies represent a major cause of ventricular arrhythmias (VA) and sudden cardiac death (SCD), frequently occurring in the absence of advanced systolic dysfunction. Traditional strategies for the primary prevention of SCD have relied predominantly on left ventricular ejection fraction (LVEF), an approach that fails to capture the substantial biological and clinical heterogeneity of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arrhythmias, Cardiac
Share to Cardiomyopathies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Death, Sudden, Cardiac

Share to Desmosomes

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Lamin Type A

Share to RNA-Binding Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 42074488
DOI: 10.3390/genes17040370
PMCID: PMC13116171

Genes

SCD
FLNC
LMNA
PLN
RBM20

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-Risk Cardiomyopathy Genotypes and Arrhythmic Risk: LMNA, FLNC, RBM20, PLN and Desmosomal Genes in the ESC 2023 Era.PMID 42074488Read ↗

Genetics in arrhythmogenic cardiomyopathies: where are we now and where are we heading to?Semantic proximity Read ↗

[Non-dilated left ventricular cardiomyopathy: beyond morphology, towards diagnostic precision].Semantic proximity Read ↗

Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment.Semantic proximity Read ↗

Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.Semantic proximity Read ↗

Challenges and Applications of Genetic Testing in Dilated Cardiomyopathy: Genotype, Phenotype and Clinical Implications.Semantic proximity Read ↗

[Cardiomyopathies: a practical approach to the assessment and management of patients and their families].Semantic proximity Read ↗

Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study.Semantic proximity Read ↗

Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failureSemantic proximity Read ↗

The clinical impact of genetic testing in comprehensive cardiomyopathies.Semantic proximity Read ↗

Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy.Semantic proximity Read ↗

[Guideline update: phenotype-based management of cardiomyopathy].Semantic proximity Read ↗

Arrhythmogenic Left Ventricular Cardiomyopathy: Genotype-Phenotype Correlations and New Diagnostic CriteriaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.